Müller C - Search Results

1

Developments toward the Implementation of ⁴⁴Sc Production at a Medical Cyclotron.

van der Meulen NP, Hasler R, Talip Z, Grundler PV, Favaretto C, Umbricht CA, Müller C, Dellepiane G, Carzaniga TS, Braccini S. van der Meulen NP, et al. Among authors: muller c. Molecules. 2020 Oct 14;25(20):4706. doi: 10.3390/molecules25204706. Molecules. 2020. PMID: 33066650 Free PMC article.

2

Folate-based radiotracers for PET imaging--update and perspectives.

Müller C. Müller C. Molecules. 2013 Apr 29;18(5):5005-31. doi: 10.3390/molecules18055005. Molecules. 2013. PMID: 23629756 Free PMC article.

3

Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.

Müller C, Bunka M, Reber J, Fischer C, Zhernosekov K, Türler A, Schibli R. Müller C, et al. J Nucl Med. 2013 Dec;54(12):2168-74. doi: 10.2967/jnumed.113.123810. Epub 2013 Nov 6. J Nucl Med. 2013. PMID: 24198390 Free article.

4

Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice.

Müller C, Fischer E, Behe M, Köster U, Dorrer H, Reber J, Haller S, Cohrs S, Blanc A, Grünberg J, Bunka M, Zhernosekov K, van der Meulen N, Johnston K, Türler A, Schibli R. Müller C, et al. Nucl Med Biol. 2014 May;41 Suppl:e58-65. doi: 10.1016/j.nucmedbio.2013.11.002. Epub 2013 Nov 15. Nucl Med Biol. 2014. PMID: 24360901

5

Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.

Müller C, Bunka M, Haller S, Köster U, Groehn V, Bernhardt P, van der Meulen N, Türler A, Schibli R. Müller C, et al. J Nucl Med. 2014 Oct;55(10):1658-64. doi: 10.2967/jnumed.114.141614. Epub 2014 Jul 17. J Nucl Med. 2014. PMID: 25034091 Free article.

6

Cyclotron production of (44)Sc: From bench to bedside.

van der Meulen NP, Bunka M, Domnanich KA, Müller C, Haller S, Vermeulen C, Türler A, Schibli R. van der Meulen NP, et al. Among authors: muller c. Nucl Med Biol. 2015 Sep;42(9):745-51. doi: 10.1016/j.nucmedbio.2015.05.005. Epub 2015 May 30. Nucl Med Biol. 2015. PMID: 26093495

7

Imaging quality of (44)Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET.

Bunka M, Müller C, Vermeulen C, Haller S, Türler A, Schibli R, van der Meulen NP. Bunka M, et al. Among authors: muller c. Appl Radiat Isot. 2016 Apr;110:129-133. doi: 10.1016/j.apradiso.2016.01.006. Epub 2016 Jan 6. Appl Radiat Isot. 2016. PMID: 26774390

8

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate.

Haller S, Pellegrini G, Vermeulen C, van der Meulen NP, Köster U, Bernhardt P, Schibli R, Müller C. Haller S, et al. Among authors: muller c. EJNMMI Res. 2016 Dec;6(1):13. doi: 10.1186/s13550-016-0171-1. Epub 2016 Feb 9. EJNMMI Res. 2016. PMID: 26860295 Free PMC article.

9

Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging.

Müller C, Vermeulen C, Johnston K, Köster U, Schmid R, Türler A, van der Meulen NP. Müller C, et al. EJNMMI Res. 2016 Dec;6(1):35. doi: 10.1186/s13550-016-0189-4. Epub 2016 Apr 23. EJNMMI Res. 2016. PMID: 27108447 Free PMC article.

10

(64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.

Farkas R, Siwowska K, Ametamey SM, Schibli R, van der Meulen NP, Müller C. Farkas R, et al. Among authors: muller c. Mol Pharm. 2016 Jun 6;13(6):1979-87. doi: 10.1021/acs.molpharmaceut.6b00143. Epub 2016 May 4. Mol Pharm. 2016. PMID: 27145400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,496 results

Search Page

Filters